Dr. Jan Drappatz, MD
Claim this profileHillman Cancer Center, University of Pittsburgh
Area of expertise
Glioblastoma
Jan Drappatz, MD has run 6 trials for Glioblastoma. Some of their research focus areas include:
Brain Cancer
Jan Drappatz, MD has run 3 trials for Brain Cancer. Some of their research focus areas include:
Affiliated Hospitals
Hillman Cancer Center, University Of Pittsburgh
University Of Pittsburgh Cancer Institute (UPCI)
Clinical Trials Jan Drappatz, MD is currently running
Multiple Therapies
for Glioblastoma
This trial is testing various treatments for patients with newly diagnosed or returning brain cancer. It adjusts treatments based on how well patients are doing to find the most effective options. The goal is to improve survival rates by matching the best treatments to specific patient types.
Recruiting
1 award
Phase 2 & 3
10 criteria
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting
1 award
Phase 2
10 criteria
More about Jan Drappatz, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Jan Drappatz, MD has experience with
- Temozolomide
- AZD1390
- Radiation Therapy
- Tirabrutinib
- VAL-083
- Troriluzole
Breakdown of trials Jan Drappatz, MD has run
Glioblastoma
Brain Cancer
Brain Tumor
Leptomeningeal Neoplasms
Hereditary Sensory Neuropathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jan Drappatz, MD specialize in?
Jan Drappatz, MD focuses on Glioblastoma and Brain Cancer. In particular, much of their work with Glioblastoma has involved IDH positive patients, or patients who are IDH negative.
Is Jan Drappatz, MD currently recruiting for clinical trials?
Yes, Jan Drappatz, MD is currently recruiting for 5 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Jan Drappatz, MD has studied deeply?
Yes, Jan Drappatz, MD has studied treatments such as Temozolomide, AZD1390, Radiation Therapy.
What is the best way to schedule an appointment with Jan Drappatz, MD?
Apply for one of the trials that Jan Drappatz, MD is conducting.
What is the office address of Jan Drappatz, MD?
The office of Jan Drappatz, MD is located at: Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15232 United States. This is the address for their practice at the Hillman Cancer Center, University of Pittsburgh.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.